Aurora Cannabis Future Growth
Future criteria checks 4/6
Aurora Cannabis is forecast to grow earnings and revenue by 133% and 10.7% per annum respectively while EPS is expected to grow by 78.3% per annum.
Key information
133.0%
Earnings growth rate
78.3%
EPS growth rate
Pharmaceuticals earnings growth | 65.0% |
Revenue growth rate | 10.7% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Dec 2024 |
Recent future growth updates
Recent updates
Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Nov 22It's Unlikely That Aurora Cannabis Inc.'s (TSE:ACB) CEO Will See A Huge Pay Rise This Year
Aug 02Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Jun 27Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem
Feb 15Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Sep 12Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)
Jun 13Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 387 | 4 | 15 | 37 | 2 |
3/31/2026 | 359 | 3 | 13 | 38 | 4 |
3/31/2025 | 329 | -12 | -2 | -6 | 6 |
9/30/2024 | 297 | -30 | -61 | -43 | N/A |
6/30/2024 | 279 | -30 | -67 | -49 | N/A |
3/31/2024 | 270 | -55 | -85 | -69 | N/A |
12/31/2023 | 266 | -116 | -91 | -71 | N/A |
9/30/2023 | 262 | -153 | -145 | -127 | N/A |
6/30/2023 | 248 | -195 | -141 | -127 | N/A |
3/31/2023 | 224 | -793 | -163 | -142 | N/A |
12/31/2022 | 212 | -1,748 | -181 | -157 | N/A |
9/30/2022 | 210 | -1,757 | -152 | -118 | N/A |
6/30/2022 | 221 | -1,718 | -142 | -110 | N/A |
3/31/2022 | 226 | -1,233 | -98 | -64 | N/A |
12/31/2021 | 231 | -381 | -122 | -82 | N/A |
9/30/2021 | 238 | -607 | -165 | -124 | N/A |
6/30/2021 | 245 | -692 | -264 | -211 | N/A |
3/31/2021 | 257 | -2,387 | -357 | -284 | N/A |
12/31/2020 | 275 | -2,359 | -430 | -285 | N/A |
9/30/2020 | 263 | -3,342 | -614 | -357 | N/A |
6/30/2020 | 269 | -3,231 | -691 | -342 | N/A |
3/31/2020 | 299 | -1,405 | -778 | -293 | N/A |
12/31/2019 | 291 | -1,430 | -787 | -289 | N/A |
9/30/2019 | 290 | -385 | -667 | -218 | N/A |
6/30/2019 | 246 | -294 | -606 | -192 | N/A |
3/31/2019 | 168 | -211 | -519 | -233 | N/A |
12/31/2018 | 119 | -72 | -439 | -206 | N/A |
9/30/2018 | 77 | 174 | -334 | -146 | N/A |
6/30/2018 | 55 | 72 | N/A | -82 | N/A |
3/31/2018 | 42 | -13 | N/A | -35 | N/A |
12/31/2017 | 31 | 7 | N/A | -16 | N/A |
9/30/2017 | 23 | -4 | N/A | -15 | N/A |
6/30/2017 | 18 | -13 | N/A | -13 | N/A |
3/31/2017 | 13 | -16 | N/A | -17 | N/A |
12/31/2016 | 8 | -13 | N/A | -11 | N/A |
9/30/2016 | 5 | -10 | N/A | -9 | N/A |
6/30/2016 | 1 | -6 | N/A | -7 | N/A |
3/31/2016 | 0 | 0 | N/A | -5 | N/A |
12/31/2015 | N/A | -3 | N/A | -3 | N/A |
9/30/2015 | N/A | -10 | N/A | -3 | N/A |
6/30/2015 | N/A | -10 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: ACB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ACB is expected to become profitable in the next 3 years.
Revenue vs Market: ACB's revenue (10.7% per year) is forecast to grow faster than the Canadian market (7.1% per year).
High Growth Revenue: ACB's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACB's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aurora Cannabis Inc. is covered by 22 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Frederico Yokota Choucair Gomes | ATB Capital Markets |
Tamy Chen | BMO Capital Markets Equity Research |
Heather Balsky | BofA Global Research |